...
首页> 外文期刊>Nutrition Journal >Double-blind placebo-controlled food challenges in children with alleged cow’s milk allergy: prevention of unnecessary elimination diets and determination of eliciting doses
【24h】

Double-blind placebo-controlled food challenges in children with alleged cow’s milk allergy: prevention of unnecessary elimination diets and determination of eliciting doses

机译:对据称对牛奶过敏的儿童进行双盲安慰剂控制的食物挑战:预防不必要的消除饮食和确定引起剂量

获取原文

摘要

Background Children with cow’s milk allergy (CMA) need a cow’s milk protein (CMP) free diet to prevent allergic reactions. For this, reliable allergy-information on the label of food products is essential to avoid products containing the allergen. On the other hand, both overzealous labeling and misdiagnosis that result in unnecessary elimination diets, can lead to potentially hazardous health situations. Our objective was to evaluate if excluding CMA by double-blind placebo-controlled food challenge (DBPCFC) prevents unnecessary elimination diets in the long term. Secondly, to determine the minimum eliciting dose (MED) for an acute allergic reaction to CMP in DBPCFC positive children. Methods All children with suspected CMA under our care (Oct’05 - Jun’09) were prospectively enrolled in a DBPCFC. Placebo and verum feedings were administered on two randomly assigned separate days. The MED was determined by noting the ‘lowest observed adverse effect level’ (LOAEL) in DBPCFC-positive children. Based on the outcomes of the DBPCFC a dietary advice was given. Parents were contacted by phone several months later about the diet of their child. Results 116 children were available for analysis. In 76 children CMA was rejected. In 60 of them CMP was successfully reintroduced, in 2 the parents refused introduction, in another 3 the parents stopped reintroduction. In 9 children CMA symptoms reappeared. In 40 children CMA was confirmed. Infants aged ≤ 12?months in our study group have a higher cumulative distribution of MED than older children. Conclusions Excluding CMA by DBPCFC successfully stopped unnecessary elimination diets in the long term in most children. The MEDs form potential useful information for offering dietary advice to patients and their caretakers.
机译:背景患有牛奶过敏(CMA)的儿童需要不含牛奶蛋白(CMP)的饮食,以防止过敏反应。为此,食品标签上可靠的过敏信息对于避免含有过敏原的产品至关重要。另一方面,过度的标签和误诊会导致不​​必要的淘汰饮食,这可能会导致潜在的健康危害。我们的目标是评估从长期来看,双盲安慰剂对照食品挑战(DBPCFC)排除CMA是否可以防止不必要的消除饮食。其次,确定DBPCFC阳性儿童对CMP的急性过敏反应的最低诱发剂量(MED)。方法前瞻性地将所有接受我们护理的可疑CMA儿童(09年10月5日至6月6日)纳入DBPCFC。安慰剂和普通喂养在两个随机分配的独立日中进行。 MED是通过注意DBPCFC阳性儿童的“最低观察到的不良反应水平”(LOAEL)来确定的。根据DBPCFC的结果,提出了饮食建议。几个月后,父母通过电话联系了他们的孩子的饮食。结果有116名儿童可供分析。在76名儿童中,CMA被拒绝了。其中60例成功地重新引入了CMP,2例父母拒绝了引入,另外3例父母停止了引入。在9名儿童中,CMA症状再次出现。在40名儿童中,确认了CMA。我们研究组中≤12个月的婴儿的MED累积分布高于大龄儿童。结论从长远来看,DBPCFC排除CMA成功地停止了大多数儿童的不必要的消除饮食。 MED形成了潜在的有用信息,可为患者及其护理者提供饮食建议。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号